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Abstract: New methods of analysis involving semiconductor nanocrystals (quantum dots [QDs]) 
as fluorescent probes have been highlighted in life science. QDs present some advantages when 
compared to organic dyes, such as size-tunable emission spectra, broad absorption bands, and 
principally exceptional resistance to photobleaching. Methods applying QDs can be simple, not 
laborious, and can present high sensibility, allowing biomolecule identification and quantification 
with high specificity. In this context, the aim of this work was to apply dual-color CdTe QDs to 
quantify red blood cell (RBC) antigen expression on cell surface by flow cytometric analysis. 
QDs were conjugated to anti-A or anti-B monoclonal antibodies, as well as to the anti-H (Ulex 
europaeus I) lectin, to investigate RBCs of A
1
, B, A
1
B, O, A
2
, and A
weak 
donors. Bioconjugates 
were capable of distinguishing the different expressions of RBC antigens, both by labeling 
efficiency and by flow cytometry histogram profile. Furthermore, results showed that RBCs from 
A
weak
 donors present fewer amounts of A antigens and higher amounts of H, when compared to 
A
1
 RBCs. In the A group, the amount of A antigens decreased as A
1
  A
3
  A
X 
= A
el
, while H 
antigens were A
X
 = A
el
  A
1
. Bioconjugates presented stability and remained active for at least 
6 months. In conclusion, this methodology with high sensibility and specificity can be applied 
to study a variety of RBC antigens, and, as a quantitative tool, can help in achieving a better 
comprehension of the antigen expression patterns on RBC membranes.
Keywords: erythrocytes, nanoparticles, ABO antigens, carbohydrates, covalent binding
Introduction
In recent years, several studies in the immunohematology field have been performed, 
mainly to investigate blood group genes.1 These immunohematological molecular 
analyses have been contributing to the study of genes related to antigens and also to 
the understanding of a great number of polymorphisms;2,3 nevertheless, they do not 
provide information regarding quantitative analyses, nor distribution, of the antigens 
on red blood cell (RBC) membrane surfaces.4 Analyses of antigen expressions are 
to this day performed by using methods based on hemagglutination, which can be 
performed in tube, microplate, and gel, with different potentiating reaction solutions.5 
These nonquantitative methods with some improvements, though not new, have 
advantages such as low cost, simplicity, and enough sensibility and specificity to 
be used in the transfusional routine. Recently, cytometric assays have been used to 
quantify antigens and to investigate more complex cases.6 Thus, we herein propose 
to apply dual-color fluorescent CdTe quantum dots (QDs) as a complementary and 
alternative method for immunohematological investigation by flow cytometry, using 
the ABO blood group as a model. The application of the QDs can contribute not only 
to the quantification, but also to the understanding of expression patterns of antigens 
on the RBC surface.
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Fluorescence-based assays present high sensitivity, 
which can provide the identification and quantification of 
biomolecules with high specificity. Moreover, new fluo-
rescent probes, such as QDs, allow researchers to take 
advantage of the full potential of fluorescence.7 QDs 
present exceptional resistance to photobleaching and a high 
reactive surface, which enables conjugations with a variety 
of biomolecules.8–12 We show here that QDs are capable 
of recognizing and evaluating A, B, and H RBC antigens 
quantitatively; in addition, QDs can be applied in a direct 
fluoroimmunoassay in living cells, with no fixation agents, 
features related to immunohematology.
To evaluate A, B, and H antigen expression, we applied 
CdTe QDs covalently bound to the antibodies anti-A and 
anti-B, as well as to the lectin Ulex europaeus I (UEA I), 
also called anti-H. UEA I lectin can recognize the H anti-
gen by L-fucose detection. CdTe QDs exhibit not only a 
narrow emission and a size-tunable fluorescence in a broad 
wavelength range (from green to infrared),13 but also a 
higher specificity and reproducibility for biological applica-
tions after bioconjugation assays, when compared to CdS/
Cd(OH)
2
 QDs already used by some of us in previous work.14 
The passivation of CdS/Cd(OH)
2
 QDs is labile and can be 
removed by bioconjugation procedures decreasing emission 
quality due to the exposure of surface defects. Moreover, to 
bioconjugate CdS/Cd(OH)
2
 QDs, stabilized with polyphos-
phate ions, is also necessary for growing a polymeric shell 
and promoting covalent couplings with biomolecules is also 
necessary, turning this process more laborious. Effective 
bioconjugations are still considered a challenge as they have 
to preserve the characteristics of the complete set: the QDs’ 
fluorescence and biomolecule biochemical functions.9 In 
this work, we also associated electrophoresis, fluorescence 
microplate assay, fluorescence correlation spectroscopy 
(FCS), and inhibition assay experiments to assure effective 
QDs bioconjugations.
There are only a few previous reports that have investi-
gated some blood antigens by flow cytometry using standard 
organic dyes.15,16 However, these studies were usually per-
formed in fixed cells and by indirect fluoroimmunoassays, 
using secondary antibodies, which can make the experiments 
more laborious and less specific. Our methodology with CdTe 
QDs enabled us to quantitatively evaluate antigens on RBC 
membranes in A
1
, A
2
, B, A
1
B, O, and in some A
weak
 groups 
both by profile and by labeling efficiency. Furthermore, we 
have also been able to correlate A and H antigen expression in 
A RBCs. We believe we show a simple method, not laborious 
and with high sensitivity, which allows antigen identification 
and quantification with high specificity and reproducibility. 
This approach can be used as a complementary tool for 
improving the comprehension of RBC biology in blood 
systems.
Experimental procedures
Synthesis and characterization of CdTe 
QDs
Aqueous colloidal dispersions of orange and green CdTe 
QDs were synthesized by adapting a previously established 
method reported by some of us.17–19 Briefly, QDs were pre-
pared by addition of Te2− (obtained from metallic tellurium 
at 10−4 mol) (Sigma Aldrich Co., St Louis, MO, USA) in a 
0.01 M CdCl
2
 or Cd(ClO
4
)
2
 (Sigma Aldrich Co.) solution with 
pH 10 in the presence of 3-mercaptossuccinic acid (MSA) 
(Sigma Aldrich Co.) as stabilizing agent. We used a 2:1:2.4 
molar ratio of Cd/Te/MSA for orange-emission QDs and 
5:1:6.0 for green-emission QDs. The Te2− aqueous solution 
was prepared by reducing metallic tellurium with NaBH
4 
(Sigma Aldrich Co.) in a 1:30 molar ratio of Te/NaBH
4
, 
respectively, at a high pH using NaOH and under nitrogen-
saturated atmosphere. The growth of the QDs proceeded, in 
inert atmosphere, with stirring at 90°C for 2 hours or 8 hours 
for green or orange emission QDs, respectively. After being 
synthesized, QDs were characterized by absorption (Evolu-
tion 600 UV-Vis; Thermo Fisher Scientific, Waltham, MA, 
USA) and emission spectroscopy (LS 55 spectrometer; 
PerkinElmer Inc., Waltham, MA, USA). The fluorescence 
spectra were obtained at 365 nm excitation. Structural char-
acterizations of QDs obtained from a very similar procedure 
have been previously described by some of us.19
Blood samples 
RBCs from A
1
, A
2
,
 
B, A
1
B, A
weak
 (A
3
, A
x
, and A
el
), as well 
as O blood donors
 
were obtained at the Hematology and 
Transfusion Center of UNICAMP (Campinas, São Paulo, 
Brazil). RBC samples (A
1
,
 
n=18; A
2
, n=10; A
3
, n=1; A
x
, n=2; 
A
el
,
 
n=1; B, n=10; A
1
B, n=6; and O, n=10) were collected in a 
4 mL ethylenediaminetetraacetic acid (EDTA) anticoagulant 
tube from healthy donors who had had their blood previ-
ously serologically typed. RBC phenotyping was performed 
using monoclonal anti-A (clone: 9113D10, lot: 71EF01EA; 
Fresenius Kabi [Barueri, São Paulo, Brazil]) and anti-B 
antibodies (clone: 9621A8, lot: 08D01A21; Fresenius Kabi), 
as well as anti-A
1
 (reference: 116005, lot: 11691-B3; Lorne 
Laboratories) and anti-H or UEA I lectin (reference 115002, 
lot: 11568-A1; Lorne Laboratories). A
2
 phenotype was dif-
ferentiated from A
1
 group by using both anti-A antibody and 
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anti-A
1
 lectin (Dolichos biflorus), as A
2
 presents agglutination 
for the anti-A antibody, though not for anti-A
1
 lectin.20
QD bioconjugation
Orange QDs were conjugated to anti-A (clone: 9113D10, 
lot: 71EF01EA; Fresenius Kabi) or anti-B (clone: 9621A8, 
lot: 08D01A21; Fresenius Kabi) by using N-ethyl-3-
(3-dimethylaminopropyl)carbodiimide hydrochloride 
(EDC) (Fluka) and N-hydroxysulfosuccinimide sodium salt 
(Sulfo-NHS) (Sigma Aldrich Co.) as coupling reagents. We 
first adjusted the pH of 2 mL of CdTe QDs (3 µM) to 5.5 
by using MSA at 4.9% (w/v). We then added 1 mL of EDC 
(at 0.4 mg⋅mL−1) and, after 5 minutes, 1 mL of Sulfo-NHS 
at 1.1 mg⋅mL−1 to the QDs sample.7,21 Fifteen minutes later, 
we added 40 µL of anti-A antibody or anti-B antibody to 
the system (the same antibodies described in the section 
“Blood samples”).
Green QDs were also covalently bonded to the UEA I 
lectin, also known as anti-H, obtained from Sigma Aldrich 
Co. (reference L5505) by using EDC and Sulfo-NHS. To this 
end, we used 1 mL of green QDs (4.5 µM), 1 mL of EDC 
(at 4.0 mg⋅mL−1), and 1 mL of Sulfo-NHS (at 10 mg⋅mL−1). 
At the end of the process, we inserted 200 µL of UEA I 
(at 0.5 mg⋅mL−1) into the system.
Prior to RBC labeling, systems were incubated with 
50 µL of Tris base (at 1 mM) for 2 hours under slow agitation. 
This procedure was used to quench the free carboxyl groups 
of nonconjugated QDs to minimize unspecific targets.
QD bioconjugation characterization
FCS analysis
FCS analysis was performed in a confocal microscopy 
(LSM 780 equipped with the software ZEN; Carl Zeiss 
Meditec AG, Jena, Germany) by using 40× water immer-
sion objective (NA =1.0, WD =2.5 mm).22 To obtain the 
correlation curves, bare orange QDs and their bioconjugates 
with anti-A (or anti-B) as well as bare green QDs and their 
bioconjugates with anti-H were, respectively, excited by a 
green (λ=514 nm) and a blue (λ=488 nm) laser, both with 
1 µW. The pinhole aperture, in both cases, was set as 35 µm. 
Ten correlation curves were obtained for each sample. From 
the correlation curves, we obtained the hydrodynamic radius 
(R) for each system using Equation 1:
 R
k T
B=
4
6 2
τ
ω
D
xπη
 (1)
where k
B
 is a Boltzmann constant, η is the medium 
viscosity, and T is the temperature. We adopted T≈303 K 
as the temperature of the sample under laser irradiation and η 
as the water viscosity at this temperature (η=7.98×10−4 Pa⋅s). 
Diffusion time t
D
 was extracted from the correlation curves 
and the lateral radius w
x
 of the focal volume (300 nm for 
514 nm excitation and 260 nm for 488 nm excitation), which 
was obtained by calibrating the system with a solution of 
rhodamine B (at 10 nM).23 As conjugated QDs show higher 
diffusion times when compared to bare QDs,22 it is possible 
to use the R measurements to confirm the bioconjugation. 
The concentrations of QDs and conjugates used for FCS 
experiments were of the order of 10–200 nM.
electrophoresis
QD conjugations to anti-A and anti-B were further confirmed 
by polyacrylamide gel electrophoresis (PAGE) technique. 
For this, we used a native and discontinuous PAGE with 
stacking gel of 6% and main gel of 9%. After polymerization, 
aliquots of each anti-A, QD, and QDs-anti-A sample were 
mixed with glycerol at ratio 5:1 (v/v) and then loaded into 
the gel wells. The systems were immersed in electrophoresis 
running buffer and PAGE proceeded at constant voltage 
(100 V) for 90 minutes. We evaluated the conjugation by 
comparing the running profiles of the samples by observing 
fluorescence signals in an L-Pix EX transilluminator (Loc-
cus Biotecnologia), and, afterward, by using the Coomassie 
blue dye (R 250) (Sigma Aldrich Co.) that binds to proteins. 
The same procedure was performed for anti-B and their 
conjugates.24
Fluorescence microplate assay
This method, developed by our group, is based on the pres-
ence or absence of fluorescence signals from samples placed 
in a fluorescence plate reader.25 For this, QDs with coupling 
agents (EDC and Sulfo-NHS), the proteins (anti-A and anti-B 
antibodies), as well as the bioconjugates (QDs-anti-A and 
QDs-anti-B) were placed in a polystyrene microplate (black 
96-well Optiplate F HB microplates; PerkinElmer Inc.). All 
systems were added in triplicate and the plate was incubated 
for 2 hours in an incubator (water bath, humid chamber) at 
37°C. After incubation, the plate was washed three times 
with phosphate-buffered saline (1×).
Fluorescence measurements were performed using a 
WALLAC 1420 plate reader with the Victor2 (PerkinElmer 
Inc.) software. The excitation band pass filter used was F405 
(405 nm/5 nm) and the emission band pass filter was F595 
(595 nm/30 nm). The acquisition time was 1 second. The 
lamp was set to 20,000 and normal slits were used for excita-
tion of samples and for collecting the emission.
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In this method, as the nonconjugated QDs do not have 
affinity for polystyrene, they are removed after washing. 
The nonremoval of the proteins presented no interference as 
these have no significative fluorescence under the conditions 
used in the experiment; only bioconjugates are capable of 
showing a significantly detectable signal. For this reason, 
QDs with coupling agents and bare proteins were used as 
our controls and the QD–protein conjugates were the systems 
tested. The intensity of the detected signal is proportional 
to bioconjugation efficiency: the higher the signal, the more 
efficient the bioconjugation.
The relative fluorescence intensity (RF) of bioconjugates 
was calculated by using the following Equation:
 RF (%) %= ×Bioconjugates FL Control FL
Control FL
−
100  (2)
where Bioconjugates FL is the average fluorescence 
intensity of the QD–biomolecule conjugates and Control 
FL is the average controls signal. According to Carvalho 
et al25 the bioconjugation was considered efficient when the 
systems showed an RF higher than 100% compared to their 
controls.
Inhibition of lectin assay
In order to prove that labeling results were due to lectin car-
bohydrate specificity, lectin binding inhibition assays26 were 
accomplished by incubating QDs-anti-H with 0.3 M L-fucose 
for 1 hour at 25°C prior to their incubation with O RBCs.
Flow cytometric analysis of RBC samples
To obtain RBCs, the blood collected in EDTA tubes was 
centrifuged at 1,700× g for 5 minutes. The pellet was then 
further washed three times in saline at 450× g for 2 minutes. 
A sample containing RBCs in saline at 1% (v/v) was then 
prepared. This procedure was used for all analyses. RBCs 
were incubated at 37°C for 1 hour for all bioconjugates.
Type A
1
 and B RBCs were incubated with QDs-anti-A 
and QDs-anti-B, respectively, using a proportion of 3:1 v/v 
(conjugated QDs:cells). Type O RBCs were incubated with 
both bioconjugates and used as the negative control, as they 
do not present A or B antigens in their membranes.
Type O, A
1
, and B RBCs were also incubated with QDs-
anti-H using a proportion of 1:1 v/v (conjugated QDs:cells). 
In this case, types A
1
 and B were used as controls as they 
show a very low H antigen expression.
Following ABO experiments, types A
2
 and A
weak
 were 
incubated with QDs-anti-A and QDs-anti-H, using the 
same procedure as aforementioned, to identify the N- 
acetylgalactosamine and L-fucose carbohydrates present on 
RBC membranes.
RBCs were analyzed by flow cytometry (FACSCalibur 
or Accuri C6; Becton Dickinson). The software programs 
used for data processing were CellQuest™ or BD Accuri 
C6 Software (Becton Dickinson) and FlowJo vX. Twenty 
thousand events (gated) were acquired. The fluorescence 
was excited at λ=488 nm and measured with an FL1 filter 
(530 nm/15 nm) or FL2 filter (585 nm/21 nm) for green and 
orange QDs, respectively.
Results and discussion
QD optical characterization
All QDs employed in the experiments were characterized by 
absorption and emission spectra, shown in Figure 1. Green 
(Figure 1A) and orange (Figure 1B) QDs presented a maximum 
emission peak at 548 nm (full width at half maximum =53 nm) 
and 610 nm (full width at half maximum =48 nm), respec-
tively. By using the first maxima of the absorption spectra, 
at 496 nm and 559 nm approximately, the average diameters 
were estimated at 2.6 nm and 3.1 nm for green and orange 
QDs, respectively.13,27 We estimated the concentration of 
nanoparticles as 4.5 µM for green QDs and 3 µM for orange 
QDs using the average sizes, Beer–Lambert law, the absorp-
tion values at the first maxima, and the extinction coefficient 
obtained by Yu et al.28 Details of this type of calculation can 
be found in previous study reported by some of us.19
Figure 1 shows that neither orange QDs-anti-A nor QDs-
anti-B presented considerable changes in the optical proper-
ties when compared to bare QDs (Figure 1D). The emission 
profile was similar for both conjugates after the bioconjuga-
tion process. Green QDs-anti-H (Figure 1C) presented a red 
shift of approximately 20 nm and orange QDs with anti-A and 
anti-B showed a small blue shift of approximately 5 nm. This 
is probably due to some modifications on the QDs’ surfaces 
caused by the binding of these biomolecules. In addition, the 
higher shift present for QDs-anti-H can be justified by the 
excess of EDC used, more than 20×, when compared to the 
anti-A or anti-B antibodies’ conjugation.
Bioconjugation analysis
A thorough characterization of the bioconjugation is 
required to avoid artifacts and nonspecific results. For this 
reason, this section is devoted to the characterization of our 
bioconjugation procedure.
A previous analysis of the bioconjugates, performed 
by us in the beginning of this study, demonstrated that the 
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Table 1 Fluorescence microplate assay results of fluorescence 
intensities and rF percentage of controls (average signal of 
antibodies and bare QDs) and bioconjugates
Systems Average signal  
(arbitrary units)
RF (%)
control a 296 –
control B 311 –
QDs-anti-a 9,261 3,023
QDs-anti-B 7,836 2,420
Notes: control a: (average signal of bare QDs [with coupling agents] + average 
signal of anti-A antibody)/2. Control B: (average signal of bare QDs [with coupling 
agents] + average signal of anti-B antibody)/2.
Abbreviations: QDs, quantum dots; RF, relative fluorescence intensity.
labeling of A RBCs presented more specificity when 15-day 
unblocked QDs-anti-A were used, indicating that bioconju-
gation was more efficient for this period of time. Therefore, 
we decided to use all conjugates at least after 15 days of 
preparation and also blocked by Tris.
QDs bioconjugated to monoclonal antibodies
In fluorescence microplate assay, control A: bare QDs (with 
coupling agents) and anti-A antibodies, showed an aver-
age signal of 296 arbitrary units and control B: bare QDs 
(with coupling agents) and anti-B antibodies presented an 
average signal of 311 arbitrary units. As QDs are removed 
after washing and antibodies do not present considerable 
autofluorescence at excitation and emission wavelengths 
used for fluorescence microplate assays (λ
exc
=405 nm and 
λ
em
=595 nm), we can consider this signal as practically 
being background detection. On the other hand, QDs-anti-A 
and QDs-anti-B showed an average signal of 9,261 and 
7,836 arbitrary units, respectively. These results correspond 
to an RF of 3,028% for QDs-anti-A and 2,420% for QDs-
anti-B, indicating efficient bioconjugation as shown in 
Table 1.
After the analysis by fluorescence microplate assay, 
we further confirmed bioconjugation by electrophoresis 
experiments (Figure 2). The proteins (Figure 2A) exhibited 
Figure 1 Optical characterization of QDs and bioconjugates. 
Notes: emission (solid lines) and absorption (dashed lines) spectra of (A) green and (B) orange QD. In (C): emission spectra of QDs-anti-h bioconjugates (dashed line) and 
green bare QDs (solid line). In (D): emission spectra of QDs-anti-a (dashed line) and QDs-anti-B (dotted lines) bioconjugates and orange bare QDs (solid line). The emission 
spectra were acquired by excitation at 365 nm.
Abbreviation: QDs, quantum dots.
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differential migration from nonconjugated (bare) QDs 
(Figure 2B). Furthermore, QDs conjugated with anti-A 
antibody (Figure 2C) presented a slow migration when 
compared with nonconjugated QDs. The electrophoresis gel 
also demonstrated that QDs were successfully conjugated to 
anti-A antibody. The same profile was observed when orange 
QDs were conjugated to anti-B (data not shown).
Fluorescence microplate assay and electrophoresis indi-
cate a successful conjugation to QDs-anti-A and QDs-anti-B; 
however, bioconjugations were further analyzed by FCS 
measurements. From the correlation curves shown in 
Figure 3, the average diffusion time for bare orange QDs was 
calculated as t=152.3 µs, while for the QDs-anti-A and QDs-
anti-B this was t=824.6 µs and t=747.0 µs, respectively. By 
using these diffusion times and Equation 1, we obtained the 
QDs’ R. Bare orange QDs showed an average hydrodynamic 
diameter of D=3.8 nm, QDs-anti-A of D=20.4 nm, and QDs-
anti-B of approximately D=18.5 nm.
As expected, bare QD sizes, obtained by FCS analy-
sis, were higher than diameters obtained by absorption 
spectra. This occurs as the R is also related to the charges 
and profiles of the QD surfaces, while the absorption is an 
optical property related to the QD core. All bioconjugates 
presented higher diameters than bare QDs. The results 
show that anti-A and anti-B antibodies were bound to QDs, 
a further confirmation of the efficacy of the bioconjuga-
tion. Typical original FCS curves and fittings are shown 
in Figure S1. 
QDs bioconjugated to anti-h lectin
Bare green QDs showed an average diffusion time of 
t=70.8 µs, while the QDs-anti-H diffusion time was 688 µs. 
Bare green QDs had an average hydrodynamic diameter 
D=2.9 nm and QDs-anti-H of D=28.9 nm, also confirming 
conjugation. Typical original FCS curves and fittings are 
shown in Figure S1.
The carbohydrate inhibition assay showed that QDs-
anti-H were not able to label O RBCs, confirming the 
bioconjugation. The fluorescence microplate assay with 
QDs-anti-H was not capable of discriminating bare QDs 
from conjugates, probably as lectin has different interactions 
$ % &
Figure 2 Page electrophoresis under a UV transilluminator. 
Notes: samples: (A) anti-a; (B) QDs with coupling agents (negative control, bare 
QDs); and (C) QDs-anti-a.
Abbreviations: PAGE, polyacrylamide gel electrophoresis; QDs, quantum dots; 
UV, ultraviolet.
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Figure 3 Normalized Fcs correlation curves of bare and conjugated QDs. 
Notes: (A) Fcs curves of bare orange QDs (solid line), QDs-anti-a (dashed line), and QDs-anti-B (dotted line). (B) Fcs curves of bare green QDs (solid line) and QDs-
anti-h (dashed line). 
Abbreviations: FCS, fluorescence correlation spectroscopy; QDs, quantum dots.
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with polystyrene. Furthermore, in the electrophoresis with 
QDs-anti-H, the visualization of the bands of the QDs with 
coupling agents was not possible. However, both FCS analy-
sis and the inhibition carbohydrates assay demonstrated that 
anti-H was successfully conjugated to QDs.
Flow cytometric analysis of RBC samples
aBO blood group incubated with QDs-anti-a and 
QDs-anti-B
Table 2 shows the percentage of RBCs labeled with their 
correspondent conjugates. Our results demonstrated that 
O RBCs did not present considerable labeling with any of 
the monoclonal antibodies. In both cases, using QDs-anti-A 
or QDs-anti-B, labeled O RBCs were less than 5%. These 
results suggest that conjugated QDs were successfully 
blocked and the labeling was specific and reproducible. 
A
1
B RBCs presented in their membranes two types 
of carbohydrates, N-acetylglucosamine (B antigen) and 
N-acetylgalactosamine (A antigen), thus A
1
B showed 98.8% 
of cells labeled with QDs-anti-A and 92% with QDs-anti-B. 
The cytometry showed that an average of 96.7% (varying 
from 95% to 98.5%) of A
1
 RBCs were labeled with QDs-
anti-A. For B RBCs incubated with QDs-anti-B, the analysis 
showed an average of 94.7% (varying from 91% to 98.8%) 
of cells labeled by these bioconjugates.
Bare QDs did not label cells nonspecifically. All results 
demonstrated that conjugates labeled RBCs of ABO blood 
groups specifically and efficiently.
Figure 4 shows typical flow cytometric profiles of A
1
, 
B, A
1
B, and O RBCs when incubated with QDs-anti-A or 
QDs-anti-B. Type O RBCs incubated with QDs-anti-A or 
QDs-anti-B showed the same pattern presented by control 
RBCs (RBCs without QDs). Our results agree with those 
presented by Aki et al15 and by Hult and Olsson.16 The 
percentage of labeled RBCs and the labeling profile were 
similar to ours in both studies, where the authors analyzed 
ABO antigens stained by a secondary antibody conjugated 
to organic dyes using an indirect immunoassay. The over-
all results demonstrated that a direct immunofluorescence 
assay using our nanotechnology methodology is capable 
of differentiating ABO RBC groups. The small deviations 
presented in Table 2 reflect the small differences of antigen 
expressions that can be found for the same blood group, 
due to the intrinsic variability of biological systems associ-
ated to the error presented by flow cytometry analysis of 
approximately 5%.
aBO blood group incubated with QDs-anti-h
Additionally, we investigated the presence or absence of H 
antigens by L-fucose analysis in ABO blood group. The aver-
age percentages of labeled cells are shown in Table 2. O type 
RBCs had the highest amount of L-fucose on the membrane; 
approximately 85% (varying from 80% to 95%) of the cells 
presented H antigens on their surfaces. O RBCs showed a 
heterogeneous distribution of L-fucose on cell membranes. 
In A
1
, B, and A
1
B groups, all or almost all of the L-fucose 
molecules were converted into A or B antigens; in this way, a 
small average labeling of 10% (A
1
, 8% [varying from 4% to 
10%]; B, 7.9% [4% to 12%]; and A
1
B, 4%) was observed. 
Typical histogram profiles are shown in Figure 5. As A
1
, B, 
and A
1
B showed similar cytometric results, we presented 
only the data for the A
1
 group (Figure 5B).
a2 and aweak groups incubated with QDs-anti-a
A
2
 and some A
weak
 phenotypes (phenotyped as A
3
, A
X
, and 
A
el
) were incubated with QDs-anti-A. Figure 6 shows typical 
histograms of A
2
 and A
weak
 types. The A
2
 subgroup presented 
an average percentage of labeled cells of 68% (varying from 
66% to 70%) and A
3 
showed approximately
 
11% of labeled 
cells, while A
X
 showed 5% and A
el
 presented similar quanti-
ties as the A
X
 subgroup.
According to the histogram profile of A
2 
(Figure 6), two 
populations were observed after incubation with QDs-anti-A: 
1) a set of unlabeled cells (approximately 35%), probably of 
RBCs with very little or without A antigens on the cell sur-
face, and 2) a set of labeled cell population (approximately 
65%) that presented A antigens on cell surface. The subgroup, 
serologically defined as A
3
,
 
with QDs-anti-A, presented a 
Table 2 average percentage of aBO blood group red blood cells labeled with conjugated QDs
Blood samples Bioconjugates 
QDs-anti-A (%) QDs-anti-B (%) QDs-anti-H (%)
O type 5 5 85 (80–90)
a1 type 96.7 (95–98.5)
a 8 (4–10)
B type a 94.7 (91–98.8) 7.9 (4–12)
a1B type 98.8 (96.0–99.7) 92 (80.5–98.2) 4 
Note: aWe did not incubate a1 type with QDs-anti-B and B1 type with QDs-anti-A. Data are represented as the mean percentage of labeled cells (range).
Abbreviation: QDs, quantum dots.
International Journal of Nanomedicine 2015:10submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
4400
cabral Filho et al
more expressive unlabeled cell population (approximately 
88%), while a smaller amount of cells showed a discrete 
labeling (approximately 12%). The A
weak
 samples, serologi-
cally defined as A
X 
and A
el
, showed a similar profile of type 
O RBCs when incubated with QDs-anti-A. In this case, we 
could not differentiate them by flow cytometry analysis. 
However, we were able to differentiate them from the other 
phenotypes. 
These results of labeling and profile obtained for A
weak
 
and A
2
 agree with those presented by Hult and Olsson16 and 
with the hemagglutination patterns of serological tests.5 
Our results for A
3
 are also consistent with the mixed-field 
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Figure 5 Histogram profiles of RBCs when incubated with QDs-anti-H. 
Notes: (A) O and (B) a1 RBCs are represented in blue in the histograms; control cells are represented in black. The X-axis represents FL1 filters (530 nm/15 nm) of the 
flow cytometer and the Y-axis represents the cell counts.
Abbreviations: QDs, quantum dots; rBcs, red blood cells.
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Figure 4 Typical flow cytometric histogram profiles of RBCs when incubated with QDs conjugated to monoclonal antibodies (blue). 
Notes: (A) O rBcs incubated with QDs-anti-a or QDs-anti-B. (B) a1 rBcs incubated with QDs-anti-a. (C) B rBcs incubated with QDs-anti-B. (D and E) a1B rBcs 
incubated with QDs-anti-A and QDs-anti-B, respectively. Control cells are represented in black. The X-axis represents the detection by FL2 filters (585 nm/21 nm) of the 
flow cytometer and the Y-axis represents cell counts.
Abbreviations: QDs, quantum dots; rBcs, red blood cells.
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Figure 6 Histogram profiles of (A) a2, (B) a3, and (C) aX rBcs when incubated with QDs-anti-a (blue). 
Notes: Control cells are represented in black. The X-axis represents FL2 filters (585 nm/21 nm) of the flow cytometer and the Y-axis represents cell counts.
Abbreviations: QDs, quantum dots; rBcs, red blood cells.
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Figure 7 Histogram profiles of (A) a2 and (B) aX rBcs when incubated with QDs-anti-h (blue). 
Notes: Control cells are represented in black. The X-axis represents FL1 filters (530 nm/15 nm) of the flow cytometer and the Y-axis represents cell counts.
Abbreviations: QDs, quantum dots; rBcs, red blood cells.
pattern displayed after agglutination reaction of RBCs with 
anti-A monoclonal antibody.4,5
a2 and aweak groups incubated with QDs-anti-h
The flow cytometric patterns of A
weak
 phenotypes are depicted 
in Figure 7B. A
X 
and A
el 
presented only 30% of labeling, 
approximately. A
X 
showed a similar profile to A
el
, with a 
smaller amount of cells labeled by QDs-anti-H. These results 
are in accordance with the serological results. However, it 
is not possible to quantify the amount of H antigens in these 
cells using serological hemagglutination reactions.5
Figure 7A shows the flow cytometric pattern of A
2
 
phenotype. According to the flow cytometry analysis, A
2
 
showed approximately 70% (varying from 60% to 80%) of 
RBCs targeted by the QDs-anti-H conjugates. These results 
can be explained by the fact that QDs-UEA I recognize the 
L-fucose of H antigens that have not yet been converted, as 
well as the L-fucose of the A
2
 antigen, which is exposed in 
the structure of this biomolecule.29 This observation can be 
supported by the similar labeling obtained by the QDs-anti-A 
and QDs- UEA I in A
2
. Further studies are needed to better 
elucidate this observation. Furthermore, in our work, we used 
the anti-H lectin from Sigma Aldrich Co. that can be more 
efficient in recognizing L-fucose when compared with the 
anti-H used in serological routine.
Conclusion
The experiments showed that anti-A, anti-B, and anti-H 
biomolecules conjugated to QDs did not lose their ability 
to efficiently recognize their respective targets on RBC 
surfaces. In this work, we used commercial and routinely 
applied monoclonal antibodies to label living RBCs, with 
no fixation procedures. Moreover, bioconjugates remained 
fluorescent, stable, and specifically labeling the cells for at 
least 6 months. This was confirmed by the results obtained 
after incubating A
1
, B, and O RBCs with their respective 
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bioconjugates, which showed approximately 100% of cells 
labeled by flow cytometry. The results are similar to those 
obtained with bioconjugates of 15 days. This gives rise to 
the possibility of using these bioconjugates in hematology 
centers with good versatility.
We have been able to differentiate the ABO groups by 
using QDs-anti-A, QDs-anti-B, and QDs-anti-H. Likewise, 
we were also able to differentiate some A phenotypes. The 
QDs conjugated to anti-H were important tools to correlate 
A and H antigens in A blood group. Type A
2
 was less labeled 
by QDs-anti-A when compared to type A
1
, while the opposite 
was shown for QDs-(UEA I) conjugate results. As discussed 
before, QDs-(UEA I) recognized in A
2
 the L-fucose of H 
antigens that were not yet converted, as well as the L-fucose 
of the A
2
 antigen, which is exposed in the structure of this 
biomolecule, thus justifying the labeling observed with these 
bioconjugates. Our results still suggest that RBCs from types 
A
X
 and A
el
 have fewer amounts of both H and A antigens. In 
the A group, the amount of A antigens decrease in the order 
A
1
  A
3
  A
X 
= A
el
. On the other hand, H antigens decrease 
in the order A
X
 = A
el
  A
1
. Further studies are needed in 
this field, mainly those that correlate molecular biology with 
immunophenotyping techniques.
Taken together, these results demonstrate a simple, 
uncomplicated, specific, quantitative, and reproducible meth-
odology that can be used as complementary and versatile 
analysis for the comprehension of RBC biology.
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Figure S1 Typical fluorescence correlation spectroscopy curves of QDs and their bioconjugates.
Notes: Correlation curve (dashed line) and a fitting of the correlation curve (solid line) of the systems are represented for (A) orange QDs, (B) QDs-anti-a, (C) QDs-anti-B, 
(D) green QDs, and (E) QDs-anti-h.
Abbreviation: QDs, quantum dots.
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